Free Trial

Tenaya Therapeutics (TNYA) SEC Filings & 10K Form

Tenaya Therapeutics logo
$1.13 +0.01 (+0.89%)
Closing price 04:00 PM Eastern
Extended Trading
$1.12 0.00 (-0.44%)
As of 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Tenaya Therapeutics SEC Filings

DateFilerForm TypeView
02/14/2025
5:42 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tenaya Therapeutics (Subject)
Form SCHEDULE 13G/A
02/10/2025
11:51 AM
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Tenaya Therapeutics (Subject)
Form SCHEDULE 13G
02/07/2025
7:29 PM
Ali Faraz (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
7:30 PM
Higa Tomohiro (Reporting)
Tenaya Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/07/2025
3:58 PM
Tenaya Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/07/2025
3:41 PM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
12:23 PM
BlackRock, Inc. (Filed by)
Tenaya Therapeutics (Subject)
Form SCHEDULE 13G/A
01/28/2025
7:00 PM
Tenaya Therapeutics (Issuer)
Tingley Whittemore (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
4:12 PM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2024
6:58 AM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2024
6:24 AM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
7:48 PM
Saito Chihiro (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
4:46 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tenaya Therapeutics (Subject)
Form SC 13G/A
11/06/2024
3:20 PM
Tenaya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/21/2024
7:35 PM
Burroughs Amy L. (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
7:37 PM
GOEDDEL DAVID V (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
7:38 PM
Lee June (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
7:39 PM
Parschauer Karah Herdman (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
7:40 PM
Srivastava Deepak (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
7:41 PM
Stehman-Breen Catherine (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
7:42 PM
Tenaya Therapeutics (Issuer)
Williams R Sanders (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
7:43 PM
Tenaya Therapeutics (Issuer)
Walsh Jeffrey T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
5:26 AM
Tenaya Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/19/2024
7:30 PM
Saito Chihiro (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
7:23 PM
Saito Chihiro (Reporting)
Tenaya Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/16/2024
7:23 PM
Ali Faraz (Reporting)
Tenaya Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
7:24 PM
Tenaya Therapeutics (Subject)
Tingley Whittemore (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
7:25 PM
Ali Faraz (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
7:26 PM
Tenaya Therapeutics (Issuer)
Tingley Whittemore (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:24 PM
Tenaya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2024
3:02 PM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
4:10 PM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:15 PM
Tenaya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
3:09 PM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
3:58 PM
Tenaya Therapeutics (Filer)
Form ARS
04/17/2024
3:15 PM
Tenaya Therapeutics (Filer)
Form DEF 14A
04/17/2024
3:17 PM
Tenaya Therapeutics (Filer)
Form DEFA14A
03/06/2024
5:45 PM
Hoey Timothy (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:28 PM
Ali Faraz (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:29 PM
PATTERSON LEONE D (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:30 PM
Tenaya Therapeutics (Issuer)
Tingley Whittemore (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Feb. 26 Could Send Nvidia’s “Silent Partners” Soaring (Ad)

Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of companies partnering with Nvidia on its latest AI Superproject … Companies we refer to as Nvidia's "Silent Partners" … And they could benefit greatly as well on Feb. 26.

Click here to find out who they are.
02/27/2024
6:31 PM
Hoey Timothy (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:05 PM
Hoey Timothy (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TNYA) was last updated on 2/20/2025 by MarketBeat.com Staff
From Our Partners